Blockchain for drug traceability: Architectures and open challenges

Mueen Uddin, Khaled Salah, Raja Jayaraman, Sasa Pesic, Samer Ellahham

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Abstract

Pharmaceutical supply chain (PSC) consists of multiple stakeholders including raw material suppliers, manufacturers, distributors, regulatory authorities, pharmacies, hospitals, and patients. The complexity of product and transaction flows in PSC requires an effective traceability system to determine the current and all previous product ownerships. In addition, digitizing track and trace process provides significant benefit for regulatory oversight and ensures product safety. Blockchain-based drug traceability offers a potential solution to create a distributed shared data platform for an immutable, trustworthy, accountable and transparent system in the PSC. In this paper, we present an overview of product traceability issues in the PSC and envisage how blockchain technology can provide effective provenance, track and trace solution to mitigate counterfeit medications. We propose two potential blockchain based decentralized architectures, Hyperledger Fabric and Besu to meet critical requirements for drug traceability such as privacy, trust, transparency, security, authorization and authentication, and scalability. We propose, discuss, and compare two potential blockchain architectures for drug traceability. We identify and discuss several open research challenges related to the application of blockchain technology for drug traceability. The proposed blockchain architectures provide a valuable roadmap for Health Informatics researchers to build and deploy an end-to-end solution for the pharmaceutical industry.

Original languageBritish English
JournalHealth Informatics Journal
Volume27
Issue number2
DOIs
StatePublished - 2021

Keywords

  • blockchain architectures
  • drug traceability
  • healthcare IT
  • Hyperledger
  • supply chain

Fingerprint

Dive into the research topics of 'Blockchain for drug traceability: Architectures and open challenges'. Together they form a unique fingerprint.

Cite this